Iromax Tablet

Iron III polymaltose + Folic acid
Panas Pharmaceutical Pvt. Ltd.
Pack size
Dispensing mode
Source
Agent
Retail Price 10.00 NPR

Indications

Iromax Tablet is used for: Iron deficiency anemia

Adult Dose

Oral One capsule/tablet daily. In more severe cases, 2 capsules a day may be required

Child Dose

Renal Dose

Administration

For maximum absorption take on empty stomach, but may take with or after meals to minimize GI irritation

Contra Indications

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Precautions

Care should be taken in patients who may develop iron overload, such as those with haemochromatosis, haemolytic anemia or red cell aplasia. Iron chelates with tetracycline and absorption may be impaired. Lactation: Excreted in breast milk

Pregnancy-Lactation

Interactions

Iron: Antacids may decrease the absorption of carbonyl iron. Folic acid: Antiepileptics, oral contraceptives, anti-TB drugs, alcohol, aminopterin, methotrexate, pyrimethamine, trimethoprim and sulphonamides may result to decrease in serum folate contrations. Decreases serum phenytoin concentrations.

Adverse Effects

Side effects of Iron III polymaltose + Folic acid : Iron >10% Constipation,Diarrhea,Nausea,Epigastric pain,Dark stools,Vomiting Frequency Not Defined Hemosiderosis (during long-term administration of large amounts),Urine discoloration,Dental stain by some formulations,Heartburn Folic acid Bronchospasm,Erythema,Malaise,Pruritus,Rash,Slight flushing

Mechanism of Action

Iron: Essential component in the formation of hemoglobin; adequate amounts of iron are necessary for effective erythropoiesis; also serves as a cofactor of several essential enzymes, including cytochromes that are involved in electron transport. Replacement of iron stores found in hemoglobin, myoglobin, and enzymes; works to transport oxygen via hemoglobin. Folic acid: Required for nucleoprotein synthesis and the maintenance of normal erythropoiesis; folic acid is converted in the liver and plasma to its metabolically active form, tetrahydrofolic acid, by dihydrofolate reductase; prevents neural tube defects in women of childbearing potential and higher doses required during pregnancy.

Note

Iromax Tablet manufactured by Panas Pharmaceutical Pvt. Ltd.. Its generic name is Iron III polymaltose + Folic acid. Iromax is availble in Nepal. Farmaco Nepal drug index information on Iromax Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Iron III polymaltose + Folic acid :